- Home
- DNLI vs KN Comparison
DNLI vs KN Comparison
Compare DNLI & KN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- KN
- Stock Information
- Founded
- DNLI 2013
- KN 1946
- Country
- DNLI United States
- KN United States
- Employees
- DNLI N/A
- KN N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- KN Consumer Electronics/Appliances
- Sector
- DNLI Health Care
- KN Consumer Staples
- Exchange
- DNLI Nasdaq
- KN Nasdaq
- Market Cap
- DNLI 1.9B
- KN 1.8B
- IPO Year
- DNLI 2017
- KN N/A
- Fundamental
- Price
- DNLI $14.37
- KN $16.44
- Analyst Decision
- DNLI Strong Buy
- KN Buy
- Analyst Count
- DNLI 15
- KN 2
- Target Price
- DNLI $33.92
- KN $20.50
- AVG Volume (30 Days)
- DNLI 1.4M
- KN 810.9K
- Earning Date
- DNLI 05-06-2025
- KN 04-24-2025
- Dividend Yield
- DNLI N/A
- KN N/A
- EPS Growth
- DNLI N/A
- KN N/A
- EPS
- DNLI N/A
- KN N/A
- Revenue
- DNLI N/A
- KN $552,400,000.00
- Revenue This Year
- DNLI N/A
- KN $4.73
- Revenue Next Year
- DNLI $384.25
- KN $6.34
- P/E Ratio
- DNLI N/A
- KN $60.59
- Revenue Growth
- DNLI N/A
- KN 23.91
- 52 Week Low
- DNLI $10.57
- KN $12.19
- 52 Week High
- DNLI $33.33
- KN $20.86
- Technical
- Relative Strength Index (RSI)
- DNLI 46.97
- KN 60.78
- Support Level
- DNLI $13.36
- KN $15.85
- Resistance Level
- DNLI $16.97
- KN $16.66
- Average True Range (ATR)
- DNLI 0.95
- KN 0.43
- MACD
- DNLI -0.06
- KN 0.15
- Stochastic Oscillator
- DNLI 28.08
- KN 90.64
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About KN Knowles Corporation
Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in three segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions, Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications and the Consumer MEMS Microphones segment designs and manufactures micro-electro-mechanical systems microphones and audio solutions used in applications. The majority of its revenue comes from the Consumer MEMS Microphones segment.